Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD...
BACKGROUND: Myelodysplastic syndromes (MDS) present with a normo- or hyperplastic bone marrow in mos...
Background: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disord...
Myelodysplastic syndrome (MDS) is a heterogeneous group of stem cell clonal alterations, culminatin...
Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Myelodysplastic syndromes (MDS) include a wide range of hematological disorders which relate to inef...
Accurate prediction of a patient’s prognosis is useful to define the risk posed by the disease. Age,...
<p>We spent multivariate analysis of clinical and laboratory parameters for the prediction of de-nov...
Although it has been shown that the percentage of bone marrow blasts in myelodysplastic syndrome (MD...
Immunohistochemistry has been introduced as a means of increasing the diagnostic accuracy of bone ma...
Myelodysplasia (MDS) is a heterogeneous disorder characterised by bone marrow failure and progressio...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Myelodysplastic syndromes (MDS) are myeloid neoplasms characterized by dysplasia in one or more cell...
PURPOSE: We studied bone marrow (BM) histologic abnormalities in myelodysplastic syndromes (MDS) cla...
Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular...
BACKGROUND: Myelodysplastic syndromes (MDS) present with a normo- or hyperplastic bone marrow in mos...
Background: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disord...
Myelodysplastic syndrome (MDS) is a heterogeneous group of stem cell clonal alterations, culminatin...
Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated wit...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Myelodysplastic syndromes (MDS) include a wide range of hematological disorders which relate to inef...
Accurate prediction of a patient’s prognosis is useful to define the risk posed by the disease. Age,...
<p>We spent multivariate analysis of clinical and laboratory parameters for the prediction of de-nov...
Although it has been shown that the percentage of bone marrow blasts in myelodysplastic syndrome (MD...
Immunohistochemistry has been introduced as a means of increasing the diagnostic accuracy of bone ma...
Myelodysplasia (MDS) is a heterogeneous disorder characterised by bone marrow failure and progressio...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Myelodysplastic syndromes (MDS) are myeloid neoplasms characterized by dysplasia in one or more cell...
PURPOSE: We studied bone marrow (BM) histologic abnormalities in myelodysplastic syndromes (MDS) cla...
Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular...
BACKGROUND: Myelodysplastic syndromes (MDS) present with a normo- or hyperplastic bone marrow in mos...
Background: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disord...
Myelodysplastic syndrome (MDS) is a heterogeneous group of stem cell clonal alterations, culminatin...